Prostate tumor cells initiate interactions with bone marrow endothelium under blood flow through binding with E-selectin, and the E-selectin-binding form of P-selectin glycoprotein ligand-1 (PSGL-1) was reportedly expressed on human bone-metastatic prostate tumor cells implicating it in bone tropism [175]. Here, SELPLG is linked to prostate neoplasm.